Webinar
Deep Tech Apex 20
Join Alumni Ventures Managing Partner Matt Caspari for an exclusive look at the Deep Tech Apex 20—a curated list of the top deep tech startups shaping the future of innovation. From quantum computing to AI-driven breakthroughs and next-generation materials, these companies are at the forefront of transforming industries.
See video policy below.
In this webinar, we’ll explore the trends driving deep tech investment, the startups leading the charge, and how venture capital is fueling groundbreaking advancements.
Whether you’re an investor, entrepreneur, or tech enthusiast, this session will provide valuable insights into the future of high-impact innovation. Don’t miss this opportunity to hear directly from a deep tech investor and gain a strategic understanding of this rapidly evolving space.
Why Attend?
- HomeExclusive Insights: Discover AV's top 20 deep tech startups driving cutting-edge advancements.
- HomeInvestment Opportunities: Learn why deep tech is a growing focus for venture capital and long-term returns.
- HomeMarket Trends: Understand the key forces shaping the next wave of disruptive technology.
Reserve your spot today and stay ahead in the world of deep tech investing. Alumni Ventures is America’s largest venture capital firm for individual investors.
About your presenter
Managing Partner, Deep Tech Fund
Matt Caspari is a Managing Partner at Alumni Ventures, where he leads the Deep Tech, Georgetown (Potomac Ventures) and UC Berkeley (Strawberry Creek Ventures) funds. He invests in mission-driven founders developing groundbreaking technologies. His investments encompass a diverse range of sectors, including AI, agriculture, aviation, battery technology, cybersecurity, direct air capture of CO2, energy generation, longevity, and robotics. Prior to Alumni Ventures, Matt gained operational experience as a two-time venture-backed founder/CEO and as a leader of the innovation team at Nike. He was the founding CEO of Aurora Biofuels, a deep tech venture that grew to 100+ employees, secured over $100 million in funding and was acquired by Reliance Industries. In earlier roles, Matt served as a strategic management consultant at Cambridge Pharma Consultancy, later acquired by IMS Health, and gained experience on the M&A team at Bloomberg. He holds a BS in Biochemistry from Georgetown University and an MBA with a Certificate in Entrepreneurship from UC Berkeley.